Regentis Biomaterials Appoints Ori Gon as CFO and Chief Business Officer
I'm PortAI, I can summarize articles.
Regentis Biomaterials Ltd. has appointed Ori Gon as Chief Financial Officer and Chief Business Officer. Gon will manage commercial and business development activities, along with financial strategy, planning, and reporting, as the company prepares for the commercial launch of GelrinC in Europe and advances its U.S. Phase III FDA trial.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments